Literature DB >> 21137156

A novel, innovative ovine model of chronic ischemic cardiomyopathy induced by multiple coronary ligations.

Jan D Schmitto1, Suyog A Mokashi, Lawrence S Lee, Rita Laurence, Hanna Schotola, Otavio Coelho-Filho, Taufiek K Rajab, Raymond Kwong, R Morton Bolman, Michael Quintel, Lawrence H Cohn, Frederick Y Chen.   

Abstract

Heart failure is one of the fastest-growing epidemics worldwide in health care today. Although a wide variety of animal models exist to create chronic heart failure, there are few truly successful, reproducible models with ischemic dilation and mitral regurgitation. Six healthy sheep (36 ± 5 kg) underwent multiple, strategic coronary artery ligations on the left ventricle (LV). Six to eight ligations were performed transmurally on three of four segments of the LV: anterior, lateral, and posterior. Side branches of the left anterior descending and circumflex arteries were ligated to create multiple, patchy areas of myocardial infarction. Cardiac global and regional systolic function was assessed by echocardiography and cardiac magnetic resonance imaging (MRI). The extent, the characteristics, and the location of the myocardial infarction were qualitatively and quantitatively assessed by late gadolinium enhancement imaging. The overall mortality rate was 16.7% (1/6 animals). Animals who survived showed a significantly reduced ejection fraction (mean 60 ± 5% to 28 ± 7%; P < 0.05); additionally, two out of the remaining five (40%) animals developed mild to moderate mitral regurgitation quantified by cardiac MRI. Furthermore, each animal developed clinical signs of heart failure (tachycardia, dyspnea, and tachypnea) consistent with global, dilated cardiomyopathy noted on MRI. Creating and reproducing a model of global, ischemic cardiomyopathy with functional mitral regurgitation is an arduous task. We have developed a promising model of ischemic heart failure using multiple ligations, which mimics the sequelae of human cardiomyopathy. Our proposed model is highly effective, reproducible, and may be used for experimental research on heart failure (cardiac assist devices, heart transplant, etc.).

Entities:  

Mesh:

Year:  2010        PMID: 21137156      PMCID: PMC3954519          DOI: 10.1111/j.1525-1594.2010.01083.x

Source DB:  PubMed          Journal:  Artif Organs        ISSN: 0160-564X            Impact factor:   3.094


  12 in total

1.  Does a suitable animal model for research on partial left ventriculectomy exist? Animal models for PLV.

Authors:  S Christiansen; U R Jahn; J Stypmann; K Redmann; H H Scheld; D Hammel
Journal:  Thorac Cardiovasc Surg       Date:  2001-10       Impact factor: 1.827

2.  Delayed development of ventricular ectopic rhythms following experimental coronary occlusion.

Authors:  A S HARRIS
Journal:  Circulation       Date:  1950-06       Impact factor: 29.690

3.  Left ventricular dilatation and diastolic compliance changes during chronic volume overloading.

Authors:  W H McCullagh; J W Covell; J Ross
Journal:  Circulation       Date:  1972-05       Impact factor: 29.690

4.  Monensin toxicosis in the domestic bovine calf: a large animal model of cardiac dysfunction.

Authors:  Kenneth N Litwak; Ashley McMahan; Karen A Lott; Laura E Lott; Steven C Koenig
Journal:  Contemp Top Lab Anim Sci       Date:  2005-05

Review 5.  Epidemiology of heart failure and left ventricular systolic dysfunction after acute myocardial infarction: prevalence, clinical characteristics, and prognostic importance.

Authors:  Robin A P Weir; John J V McMurray; Eric J Velazquez
Journal:  Am J Cardiol       Date:  2006-04-21       Impact factor: 2.778

6.  An ovine model of postinfarction dilated cardiomyopathy.

Authors:  Sina L Moainie; Joseph H Gorman; T Sloane Guy; Frank W Bowen; Benjamin M Jackson; Theodore Plappert; Navneet Narula; Martin G St John-Sutton; Jagat Narula; L Henry Edmunds; Robert C Gorman
Journal:  Ann Thorac Surg       Date:  2002-09       Impact factor: 4.330

7.  Induction of chronic cardiac insufficiency by arteriovenous fistula and doxorubicin administration.

Authors:  Dominique Tessier; Paul Lajos; Eric Braunberger; Jean-Louis Pouchelon; Alain Carpentier; Juan Carlos Chachques; Valerie Chetboul
Journal:  J Card Surg       Date:  2003 Jul-Aug       Impact factor: 1.620

8.  Hemodynamic changes in a model of chronic heart failure induced by multiple sequential coronary microembolization in sheep.

Authors:  Jan Dieter Schmitto; Kasim Oguz Coskun; Sinan Tolga Coskun; Philipp Ortmann; Tobias Vorkamp; Florian Heidrich; Samuel Sossalla; Aron-Frederik Popov; Theodor Tirilomis; José Hinz; Jan Heuer; Michael Quintel; Frederick Yen-Ching Chen; Friedrich Albert Schöndube
Journal:  Artif Organs       Date:  2009-10-10       Impact factor: 3.094

9.  Chronic heart failure induced by multiple sequential coronary microembolization in sheep.

Authors:  J D Schmitto; P Ortmann; R Wachter; E Hintze; A F Popov; P Kolat; O J Liakopoulos; R Waldmann-Beushausen; H Dörge; M Grossmann; R Seipelt; F A Schöndube
Journal:  Int J Artif Organs       Date:  2008-04       Impact factor: 1.595

Review 10.  The stunned myocardium: prolonged, postischemic ventricular dysfunction.

Authors:  E Braunwald; R A Kloner
Journal:  Circulation       Date:  1982-12       Impact factor: 29.690

View more
  3 in total

1.  Prophylactic amiodarone and lidocaine improve survival in an ovine model of large size myocardial infarction.

Authors:  Tieluo Li; Xufeng Wei; A Claire Watkins; Pablo G Sanchez; Zhongjun J Wu; Bartley P Griffith
Journal:  J Surg Res       Date:  2013-06-07       Impact factor: 2.192

2.  The Structure-function remodeling in rabbit hearts of myocardial infarction.

Authors:  Haotian Wu; Li Li; Pei Niu; Xu Huang; Jinyi Liu; Fengshun Zhang; Wenzeng Shen; Wenchang Tan; Yiling Wu; Yunlong Huo
Journal:  Physiol Rep       Date:  2017-06

3.  A nonthoracotomy myocardial infarction model in an ovine using autologous platelets.

Authors:  Tyler Spata; Daniel Bobek; Bryan A Whitson; Sampath Parthasarathy; Peter J Mohler; Robert S D Higgins; Ahmet Kilic
Journal:  Biomed Res Int       Date:  2013-12-03       Impact factor: 3.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.